Abstract
Both hemodynamic and hormonal factors associated with normal pregnancy impose a burden on the aorta, which may have detrimental effects in case of underlying aortic fragility. Timely and correct diagnosis and recognizing the risks of pregnancy are key factors in preventing complications such as aneurysmal growth, aortic dissection or worsening aortic regurgitation. Counseling, starting well ahead of pregnancy, management and follow-up by an experienced multidisciplinary team is mandatory in women with underlying aortic disease. In this chapter we will review the most relevant diseases associated with an increased risk for aortic complications and provide recommendations for optimal care before, during and after pregnancy and delivery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACE:
-
Angiotensin converting enzyme
- ART:
-
Assisted reproductive technologies
- ASI:
-
Aortic size index
- ASRM:
-
American Society for Reproductive Medicine
- BAV:
-
Bicuspid aortic valve
- BSA:
-
Body surface area
- C-:
-
Caesarean
- ESC:
-
European Society of Cardiology
- FBN1:
-
Fibrillin 1 gene
- HTAD:
-
Heritable thoracic aortic disorders
- IRAD:
-
International Registry of Aortic Dissections
- IUGR:
-
Intrauterine growth retardation
- LDS:
-
LoeysāDietz syndrome
- MAC:
-
Montalcino Aortic Consortium
- MFS:
-
Marfan syndrome
- PGD:
-
Preimplantation diagnosis
- PND:
-
Prenatal diagnosis
- TAAD:
-
Thoracic aortic aneurysms and dissections
- TAAs:
-
Thoracic aortic aneurysms
- TAD:
-
Thoracic aortic dissection
- TS:
-
Turner syndrome
- vEDS:
-
Vascular EhlersāDanlos syndrome
- VSMC:
-
Vascular Smooth Muscle Cells
References
Westerhof N, Lankhaar J-W, Westerhof BE (2009) The arterial Windkessel. Med Biol Eng Comput 47(2):131ā141
Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE et al (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121:e266āe369
Devereux RB, de Simone G, Arnett DK, Best LG, Boerwinkle E, Howard BV et al (2012) Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ā„15 years of age. Am J Cardiol 110(8):1189ā1194
Campens L, Demulier L, De Groote K, Vandekerckhove K, De Wolf D, Roman MJ et al (2014) Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. Am J Cardiol 114(6):914ā920
Hannuksela M, Lundqvist S, Carlberg B (2006) Thoracic aorta ā dilated or not? Scand Cardiovasc J 40(3):175ā178
Braverman AC, Thompson RW, Sanchez LA (2012) Diseases of the aorta. In: Mann DL, Zipes DP, Libby P (eds) Braunwaldās heart disease, 9th edn. Elsevier Saunders, Philadelphia, pp 1309ā1337
Halloran BG, Davis VA, McManus BM, Lynch TG, Baxter BT (1995) Localization of aortic disease is associated with intrinsic differences in aortic structure. J Surg Res 59(1):17ā22
Sidloff D, Choke E, Stather P, Bown M, Thompson J, Sayers R (2014) Mortality from thoracic aortic diseases and associations with cardiovascular risk factors. Circulation 130(25):2287ā2294
Immer FF, Bansi AG, Immer-Bansi AS, McDougall J, Zehr KJ, Schaff HV et al (2003) Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg 76(1):309ā314
Landenhed M, Engstrƶm G, GottsƤter A, Caulfield MP, Hedblad B, Newton-Cheh C et al (2015) Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study. J Am Heart Assoc 4(1):e001513
Nienaber CA (2003) Aortic dissection: new frontiers in diagnosis and management: part II: therapeutic management and follow-up. Circulation 108(6):772ā778
Pacini D, Di Marco L, Fortuna D, Belotti LMB, Gabbieri D, Zussa C et al (2013) Acute aortic dissection: epidemiology and outcomes. Int J Cardiol 167(6):2806ā2812
Nienaber CA (2003) Aortic dissection: new frontiers in diagnosis and management: part I: from etiology to diagnostic strategies. Circulation [Internet] 108(5):628ā635
Hanna JM, Andersen ND, Ganapathi AM, McCann RL, Hughes GC (2014) Five-year results for endovascular repair of acute complicated type B aortic dissection. J Vasc Surg 59(1):96ā106
Nienaber CA, Fattori R, Mehta RH, Richartz BM, Evangelista A, Petzsch M et al (2004) Gender-related differences in acute aortic dissection. Circulation 109(24):3014ā3021
Guo D-C, Papke CL, He R, Milewicz DM (2006) Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci 1085:339ā352
Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB et al (2010) The revised Ghent nosology for the Marfan syndrome. J Med Genet 47(7):476ā485
Judge DP, Dietz HC (2005) Marfanās syndrome. Lancet 366(9501):1965ā1976
Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352(6333):337ā339
Yetman AT, Bornemeier RA, McCrindle BW (2003) Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? JAC 41(2):329ā332
Pepin M, Schwarze U, Superti-Furga A, Byers PH (2000) Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 342(10):673ā680
Barbier M, Gross M-S, Aubart M, Hanna N, Kessler K, Guo D-C et al (2014) MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet 95(6):736ā743
Renard M, Holm T, Veith R, Callewaert BL, s LCAE, Baspinar O et al (2010) Altered TGF & beta; signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. Eur J Hum Genet 18(8):895ā901
Callewaert B, Renard M, Hucthagowder V, Albrecht B, Hausser I, Blair E et al (2011) New insights into the pathogenesis of autosomal-dominant cutis laxa with report of five ELN mutations. Hum Mutat 32(4):445ā455
Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T et al (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37(3):275ā281
Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H et al (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355(8):788ā798
van der Linde D, van de Laar IMBH, Bertoli-Avella AM, Oldenburg RA, Bekkers JA, Mattace-Raso FUS et al (2012) Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. JAC [Internet] Elsevier Inc 60(5):397ā403
van de Laar IMBH, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JMA et al (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43(2):121ā126
van de Laar IMBH, van der Linde D, Oei EHG, Bos PK, Bessems JH, Bierma-Zeinstra SM et al (2011) Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet [Internet] 49(1):47ā57
van der Linde D, Verhagen HJM, Moelker A, van de Laar IMBH, Van Herzeele I, De Backer J et al (2012) Aneurysm-osteoarthritis syndrome with visceral and iliac artery aneurysms. YMVA [Internet] Elsevier Inc 57(1):96ā102
Guo D-C, Hanna N, Regalado ES, Detaint D, Gong L, Varret M et al (2012) TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet. Nature Publishing Group, p 1ā8
Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J et al (2012) Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet [Internet]. Nature Publishing Group, p 1ā7
Renard M, Callewaert B, Malfait F, Campens L, Sharif S, Del Campo M et al (2012) Thoracic aortic-aneurysm and dissection in association with significant mitral valve disease caused by mutations in TGFB2. Int J Cardiol [Internet] Elsevier Ireland Ltd 165(3):584ā587
Bertoli-Avella AM, Gillis E, Morisaki H, Verhagen JMA, de Graaf BM, van de Beek G et al (2015) Mutations in a TGF-Ī² Ligand, TGFB3, cause syndromic aortic aneurysms and dissections. J Am Coll Cardiol 65(13):1324ā1336
Morisaki H, Akiko Y, Itaru Y, Razia S, Tatsuya O, Hiroshu T (2014) Pathogenic mutations found in 3 Japanese families with MFS/LDS-like disorder. Presented at the biannual meeting on Marfan syndrome and related disorders. Paris, Fr
Matyas G, Naef P, Oexle K (2014) De novo TGFB3 mutation in a patient with overgrowth and Loeys-Dietz syndrome features. Presented at the biannual meeting on Marfan syndrome and related disorders, Paris, Fr, Paris
Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, Schepers D et al (2012) Mutations in the TGF-Ī² repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet 44(11):1249ā1254
Carmignac V, Thevenon J, AdĆØs L, Callewaert B, Julia S, Thauvin-Robinet C et al (2012) In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. Am J Hum Genet [Internet] Am Soc Hum Genet 91(5):950ā957
Andrabi S, Bekheirnia MR, Robbins-Furman P, Lewis RA, Prior TW, Potocki L (2011) SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. Am J Med Genet A 155A(5):1165ā1169
Reinstein E, Frentz S, Morgan T, GarcĆa-MiƱaĆŗr S, Leventer RJ, McGillivray G et al (2013) Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A. Eur J Hum Genet 21(5):494ā502
Renard M, Callewaert B, Baetens M, Campens L, Macdermot K, Fryns J-P et al (2011) Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFbeta signaling in FTAAD. Int J Cardiol [Internet] 165(2):314ā321
Guo D-C, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N et al (2007) Mutations in smooth muscle Ī±-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39(12):1488ā1493
Guo D-C, Regalado E, Casteel DE, Santos-Cortez RL, Gong L, Kim JJ et al (2013) Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet 93(2):398ā404
Pannu H, Tran-Fadulu V, Papke CL, Scherer S, Liu Y, Presley C et al (2007) MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet 16(20):2453ā2462
Wang L, Guo D-C, Cao J, Gong L, Kamm KE, Regalado E et al (2010) Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet Am Soc Hum Genet 87(5):701ā707
Humphrey JD, Milewicz DM, Tellides G, Schwartz MA (2014) Cell biology. Dysfunctional mechanosensing in aneurysms. Science 344(6183):477ā479
Schnitker M, Bayer C (1944) Dissecting aneurysm of the aorta in young individuals, particularly in association with pregnancy: with report of a case. Ann Intern Med 20:486ā511
Thalmann M, Sodeck GH, Domanovits H, Grassberger M, Loewe C, Grimm M et al (2011) Acute type A aortic dissection and pregnancy: a population-based study. Eur J Cardiothorac Surg [Internet] Eur Assoc Cardio-Thorac Surg 39(6):e159āe163
Nasiell J, Lindqvist PG (2010) Aortic dissection in pregnancy: the incidence of a life-threatening disease. Eur J Obstet Gynecol Reprod Biol 149(1):120ā121
Wilkinson H, Trustees and Medical Advisers (2011) Saving mothersā lives. Reviewing maternal deaths to make motherhood safer: 2006ā2008. BJOG: Int J Obstet Gynecol 118(11):1402ā1403; discussion1403ā1404
Rajagopalan S, Nwazota N, Chandrasekhar S (2014) Outcomes in pregnant women with acute aortic dissections: a review of the literature from 2003 to 2013. Int J Obstet Anesth 23(4):348ā356
Huisman CM, Zwart JJ, Roos-Hesselink JW, Duvekot JJ, van Roosmalen J (2013) Incidence and predictors of maternal cardiovascular mortality and severe morbidity in The Netherlands: a prospective cohort study. PLoS One 8(2):e56494
Bouvier-Colle M-H, Deneux-Tharaux C, del Carmen Saucedo M (2013) Les Morts Maternelles en France. Mieux comprendre pour mieux prĆ©venir. www.inserm.fr, p 1ā120
Oskoui R, Lindsay J (1994) Aortic dissection in women. AJC 73(11):821ā823
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al (2011) ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32:3147ā3197
Sanghavi M, Rutherford JD (2014) Cardiovascular physiology of pregnancy. Circulation 130(12):1003ā1008
Regitz-Zagrosek V, Gohlke-BƤrwolf C, Iung B, Pieper PG (2014) Management of cardiovascular diseases during pregnancy. Curr Probl Cardiol 39(4ā5):85ā151
Pyeritz RE (2014) Heritable thoracic aortic disorders. Curr Opin Cardiol 29(1):97ā102
De Backer J, Loeys B, Leroy B, Coucke P, DIETZ H, de Paepe A (2007) Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome. Clin Genet 72(3):188ā198
Jondeau G, Detaint D, Tubach F, Arnoult F, Milleron O, Raoux F et al (2012) Aortic event rate in the Marfan population: a cohort study. Circulation 125(2):226ā232
de Backer JF, Devos D, Segers P, Matthys D, FranƧois K, Gillebert TC et al (2006) Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol [Internet] 112(3):353ā358
Alpendurada F, Wong J, Kiotsekoglou A, Banya W, Child A, Prasad SK et al (2010) Evidence for Marfan cardiomyopathy. Eur J Heart Fail 12(10):1085ā1091
Kiotsekoglou A, Bajpai A, Bijnens BH, Kapetanakis V, Athanassopoulos G, Moggridge JC et al (2008) Early impairment of left ventricular long-axis systolic function demonstrated by reduced atrioventricular plane displacement in patients with Marfan syndrome. Eur J Echocardiogr 9(5):605ā613
Rybczynski M, Mir TS, Sheikhzadeh S, Bernhardt AMJ, Schad C, Treede H et al (2010) Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome. AJC [Internet] Elsevier Inc 106(7):1048ā1053
Hoffmann BA, Rybczynski M, Rostock T, Servatius H, Drewitz I, Steven D et al (2012) Prospective risk stratification of sudden cardiac death in Marfan's syndrome. Int J Cardiol [Internet]. Elsevier Ireland Ltd, p 1ā7. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=22738784&retmode=ref&cmd=prlinks
Pyeritz RE (1981) Maternal and fetal complications of pregnancy in the Marfan syndrome. Am J Med 71(5):784ā790
Elkayam U, Ostrzega E, Shotan A, Mehra A (1995) Cardiovascular problems in pregnant women with the Marfan syndrome. Ann Intern Med 123(2):117ā122
Goland S, Elkayam U (2009) Cardiovascular problems in pregnant women with Marfan syndrome. Circulation 119(4):619ā623
Lalchandani S, Wingfield M (2003) Pregnancy in women with Marfanās syndrome. Eur J Obstet Gynecol 110(2):125ā130
Lind J, Wallenburg HC (2001) The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol 98(1):28ā35
Pacini L, Digne F, Boumendil A, Muti C, Detaint D, Boileau C et al (2009) Maternal complication of pregnancy in Marfan syndrome. Int J Cardiol 136(2):156ā161
Donnelly RT, Pinto NM, Kocolas I, Yetman AT (2012) The immediate and long-term impact of pregnancy on aortic growth rate and mortality in women with Marfan syndrome. JAC Elsevier Inc 60(3):224ā229
Mulder BJM, Meijboom LJ (2012) Pregnancy and Marfan syndrome. JAC Elsevier Inc 60(3):230ā231
Meijboom LJ (2005) Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 26(9):914ā920
Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE (1995) A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 173(5):1599ā1606
Omnes S, Jondeau G, Detaint D, Dumont A, Yazbeck C, Guglielminotti J et al (2013) Pregnancy outcomes among women with Marfan syndrome Int J Gynecol Obstet 122(3):219ā223
Hassan N, Patenaude V, Oddy L, Abenhaim HA (2015) Pregnancy outcomes in Marfan syndrome: a retrospective study. Am J Perinatol 30(2):123ā302
Attias D, Stheneur C, Roy C, Collod-Beroud G, Detaint D, Faivre L et al (2009) Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 120(25):2541ā2549
Ong K-T, Perdu J, De Backer J, Bozec E, Collignon P, Emmerich J et al (2010) Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet 376(9751):1476ā1484
Lurie S, Manor M, Hagay ZJ (1998) The threat of type IV Ehlers-Danlos syndrome on maternal well-being during pregnancy: early delivery may make the difference. J Obstet Gynaecol 18(3):245ā248
Rudd NL, Nimrod C, Holbrook KA, Byers PH (1983) Pregnancy complications in type IV Ehlers-Danlos syndrome. Lancet 1(8314ā5):50ā53
Murray ML, Pepin M, Peterson S, Byers PH (2014) Pregnancy-related deaths and complications in women with vascular Ehlers-Danlos syndrome. Genet Med 16(12):874ā880
Lind J, Wallenburg HCS (2002) Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand 81(4):293ā300
Regalado ES, Guo D-C, Estrera AL, Buja LM, Milewicz DM (2013) Acute aortic dissections with pregnancy in women with ACTA2 mutations. Am J Med Genet A. Nov 15
Mortensen KH, Andersen NH, Gravholt CH (2012) Cardiovascular phenotype in Turner syndrome ā integrating cardiology, genetics, and endocrinology. Endocr Rev 33(5):677ā714
Sachdev V, Matura LA, Sidenko S, Ho VB, Arai AE, Rosing DR et al (2008) Aortic valve disease in Turner syndrome. J Am Coll Cardiol 51(19):1904ā1909
Mortensen KH, Hjerrild BE, Stochholm K, Andersen NH, SĆørensen KE, Lundorf E et al (2011) Dilation of the ascending aorta in Turner syndrome ā a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 13:24
Matura LA, Ho VB, Rosing DR, Bondy CA (2007) Aortic dilatation and dissection in Turner syndrome. Circulation 116(15):1663ā1670
Gravholt CH, Landin-Wilhelmsen K, Stochholm K, Hjerrild BE, Ledet T, Djurhuus CB et al (2006) Clinical and epidemiological description of aortic dissection in Turnerās syndrome. Cardiol Young 16(5):430ā436
Carlson M, Silberbach M (2007) Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. J Med Genet 44(12):745ā749
Practice Committee of American Society For Reproductive Medicine (2012) Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 97(2):282ā284
Tarani L, Lampariello S, Raguso G, Colloridi F, Pucarelli I, Pasquino AM et al (1998) Pregnancy in patients with Turnerās syndrome: six new cases and review of literature. Gynecol Endocrinol 12(2):83ā87
Birkebaek NH, Cruger D, Hansen J, Nielsen J, Bruun-Petersen G (2002) Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin Genet 61(1):35ā39
Chevalier N, Letur H, Lelannou D, Ohl J, Cornet D, Chalas-Boissonnas C et al (2011) Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy follow-up are associated with poor outcome. J Clin Endocrinol Metab 96(2):E260āE267
Hagman A, KƤllĆ©n K, Bryman I, Landin-Wilhelmsen K, BarrenƤs M-L, Wennerholm U-B (2013) Morbidity and mortality after childbirth in women with Turner karyotype. Hum Reprod 28(7):1961ā1973
Hagman A, Loft A, Wennerholm U-B, Pinborg A, Bergh C, AittomƤki K et al (2013) Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod 28(6):1598ā1609
van Hagen IM, Roos-Hesselink JW (2014) Aorta pathology and pregnancy. Best Pract Res Clin Obstet Gynaecol 28:537
Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312(5770):117ā121
Forteza A, Evangelista A, SƔnchez V, Teixido-Tura G, Sanz P, GutiƩrrez L et al (2015) Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial. Eur Heart J. Oct 29
Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD et al (2014) Atenolol versus losartan in children and young adults with Marfanās syndrome. N Engl J Med 371(22):2061ā2071
Milleron O, Arnoult F, Ropers J, Aegerter P, Detaint D, Delorme G et al (2015) Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur Heart J. May 2
Magee LA, Duley L (2000) Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev (4):CD002863
Ruys TPE, Maggioni A, Johnson MR, Sliwa K, Tavazzi L, Schwerzmann M et al (2014) Cardiac medication during pregnancy, data from the ROPAC. Int J Cardiol 177(1):124ā128
Kofahl B, Henke D, Hettenbach A, Mutschler E (1993) Studies on placental transfer of celiprolol. Eur J Clin Pharmacol 44(4):381ā382, Springer
Gott VL, Greene PS, Alejo DE, Cameron DE, Naftel DC, Miller DC et al (1999) Replacement of the aortic root in patients with Marfanās syndrome. N Engl J Med 340(17):1307ā1313
John AS, Gurley F, Schaff HV, Warnes CA, Phillips SD, Arendt KW et al (2011) Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 91(4):1191ā1196
Yates MT, Soppa G, Smelt J, Fletcher N, van Besouw J-P, Thilaganathan B et al (2015) Perioperative management and outcomes of aortic surgery during pregnancy. J Thorac Cardiovasc Surg 149(2):607ā610
Chambers CE, Clark SL (1994) Cardiac surgery during pregnancy. Clin Obstet Gynecol 37(2):316ā323
Gordon CF, Johnson MD (1993) Anesthetic management of the pregnant patient with Marfan syndrome. J Clin Anesth 5(3):248ā251
Ruys TPE, Cornette J, Roos-Hesselink JW (2013) Pregnancy and delivery in cardiac disease. J Cardiol 61(2):107ā112
Simpson LL, Athanassious AM, D'Alton ME (1997) Marfan syndrome in pregnancy. Curr Opin Obstet Gynecol 9(5):337ā341
Allyn J, Guglielminotti J, Omnes S, Guezouli L, Egan M, Jondeau G et al (2013) Marfanās syndrome during pregnancy: anesthetic management of delivery in 16 consecutive patients. Anesth Analg 116(2):392ā398
Meijboom LJ, Drenthen W, Pieper PG, Groenink M, van der Post JAM, Timmermans J et al (2006) Obstetric complications in Marfan syndrome. Int J Cardiol 110(1):53ā59
Lipscomb KJ, Smith JC, Clarke B, Donnai P, Harris R (1997) Outcome of pregnancy in women with Marfanās syndrome. Br J Obstet Gynaecol 104(2):201ā206
von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355(9198):87ā92
Hunter S, Robson SC (1992) Adaptation of the maternal heart in pregnancy. Heart 68(6):540ā543
Robson SC, Dunlop W, Hunter S (1987) Haemodynamic changes during the early puerperium. Br Med J (Clin Res Ed) 294(6579):1065
Roos-Hesselink JW, Ruys PTE, Johnson MR (2013) Pregnancy in adult congenital heart disease. Curr Cardiol Rep 15(9):401
Natoli AK, Medley TL, Ahimastos AA, Drew BG, Thearle DJ, Dilley RJ et al (2005) Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension 46(5):1129ā1134
Robb AO, Mills NL, Din JN, Smith IBJ, Paterson F, Newby DE et al (2009) Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension 53(6):952ā958
Ulusoy RE, Demiralp E, Kirilmaz A, Kilicaslan F, Ozmen N, Kucukarslan N et al (2006) Aortic elastic properties in young pregnant women. Heart Vessels 21(1):38ā41
Easterling TR, Benedetti TJ, Schmucker BC, Carlson K, Millard SP (1991) Maternal hemodynamics and aortic diameter in normal and hypertensive pregnancies. Obstet Gynecol 78(6):1073ā1077
Cabanes L, Chalas C, Christin-Maitre S, Donadille B, Felten ML, Gaxotte V et al (2010) Turner syndrome and pregnancy: clinical practice. Recommendations for the management of patients with Turner syndrome before and during pregnancy. Eur J Obstet Gynecol Reprod Biol 152(1):18ā24
Boodhwani M, Andelfinger G, Leipsic J, Lindsay T, McMurtry MS, Therrien J et al (2014) Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. Can J Cardiol 30:577ā589
Coron F, Rousseau T, Jondeau G, Gautier E, Binquet C, Gouya L et al (2012) What do French patients and geneticists think about prenatal and preimplantation diagnoses in Marfan syndrome? Prenat Diagn 32(13):1318ā1323
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Disclosures
J. De Backer holds a grant as Senior Clinical Investigator from the Fund for Scientific Research (FWO), Flanders (Belgium). L. Muino Mosquera is supported by a doctoral fellowship from the Special Research Fund (BOF) of the University of Ghent (Belgium).
Rights and permissions
Copyright information
Ā© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
De Backer, J., MuiƱo-Mosquera, L., Demulier, L. (2017). Aortopathy. In: Roos-Hesselink, J., Johnson, M. (eds) Pregnancy and Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-38913-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-38913-4_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-38911-0
Online ISBN: 978-3-319-38913-4
eBook Packages: MedicineMedicine (R0)